Genome-wide localization of small molecules

Nature Biotechnology (Impact Factor: 41.51). 12/2013; 32(1). DOI: 10.1038/nbt.2776
Source: PubMed


A vast number of small-molecule ligands, including therapeutic drugs under development and in clinical use, elicit their effects by binding specific proteins associated with the genome. An ability to map the direct interactions of a chemical entity with chromatin genome-wide could provide important insights into chemical perturbation of cellular function. Here we describe a method that couples ligand-affinity capture and massively parallel DNA sequencing (Chem-seq) to identify the sites bound by small chemical molecules throughout the human genome. We show how Chem-seq can be combined with ChIP-seq to gain unique insights into the interaction of drugs with their target proteins throughout the genome of tumor cells. These methods will be broadly useful to enhance understanding of therapeutic action and to characterize the specificity of chemical entities that interact with DNA or genome-associated proteins.

Download full-text


Available from: Alla A Sigova, Oct 17, 2014
  • Source
    • "A recent study identified BET inhibitors with a preference for BD2 over BD1, and such compounds led to minimal transcriptional effects when compared to JQ1 (Picaud et al., 2013). Selective inhibitors of individual BET family members would also be anticipated to cause distinct effects on transcription, since the genome occupancy patterns Brd2/Brd3/Brd4 are not identical (Anders et al., 2014). Brd2 has been linked to metabolic regulation and lymphomagenesis; however, little is known about the biological function of Brd3 in vivo (Greenwald et al., 2004; Wang et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The bromodomain and extraterminal (BET) protein Brd4 recruits transcriptional regulatory complexes to acetylated chromatin. While Brd4 is considered to be a general transcriptional regulator, pharmacological inhibition of BET proteins shows therapeutic activity in a variety of different pathologies, particularly in models of cancer and inflammation. Such effects have been attributed to a specific set of downstream target genes whose expression is disproportionately sensitive to pharmacological targeting of BET proteins. Emerging evidence links the transcriptional consequences of BET inhibition to the association of Brd4 with enhancer elements, which tend to be involved in lineage-specific gene regulation. Furthermore, Brd4 engages in direct regulatory interactions with several DNA-binding transcription factors to influence their disease-relevant functions. Here we review the current understanding of molecular mechanisms that underlie the promising therapeutic effects of BET bromodomain inhibition.
    Full-text · Article · Jun 2014 · Molecular cell
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cat-anionic vesicles were prepared by mixing non stoichiometric amounts of sodium bis-2-ethylhexylsulfosuccinate and dioctyldimethylammonium bromide in water. Depending on the concentration and mole ratios between the surfactants, cat-anionic vesicular aggregates are formed in part of the phase diagram. They have either negative or positive charges in excess and are endowed with significant thermodynamic and kinetic stability. Vesicle characterization was performed by combining dynamic light scattering and electro-phoretic mobility. It was inferred that vesicle size scales in inverse proportion with its surface charge density, diverges as the latter quantity approaches zero, and/or the mole ratio equals unity. Therefore, both variables are controlled by the anionic/cationic mole ratio. Small angle X-ray scattering, in addition, indicates that vesicles are uni-lamellar. Selected anionic vesicular systems were reacted with poly-L-lysine hydrobromide, or lysozyme. Polymer binding continues until an almost complete neutralization of the negatively charged sites on the vesicles surface is attained, as inferred by electro-phoretic mobility. Lipo-plexes are formed as a result of significant electrostatic interactions between cationic poly-electrolytes and negatively charged vesicles.
    Full-text · Article · Feb 2014 · Langmuir
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Here we report the design, synthesis, and biochemical characterization of a new chemical tool, UNC0965. UNC0965 is a biotinylated version of our previously reported G9a chemical probe, UNC0638. Importantly, UNC0965 maintains high in vitro potency and is cell penetrant. The biotinylated tag of UNC0965 enables "chemiprecipitation" of G9a from whole cell lysates. Further, the cell penetrance of UNC0965 allowed us to explore the localization of G9a on chromatin both in vitro and in vivo through chemical inhibitor-based chromatin immunoprecipitation (chem-ChIP).
    Full-text · Article · Mar 2014 · ChemMedChem
Show more